Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

被引：21
作者：
Purdue, M. P. [1 ,2 ]
Lan, Q. [1 ]
Kemp, T. J. [3 ]
Hildesheim, A. [1 ]
Weinstein, S. J. [1 ]
Hofmann, J. N. [1 ]
Virtamo, J. [4 ]
Albanes, D. [1 ]
Pinto, L. A. [3 ]
Rothman, N. [1 ]
机构：
[1] NCI, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA
[2] Ontario Inst Canc Res, Toronto, ON, Canada
[3] Leidos Biomed Inc, HPV Immunol Lab, Frederick Natl Lab Canc Res, Frederick, MD USA
[4] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland
来源：
LEUKEMIA | 2015年 / 29卷 / 06期
关键词：
B-CELL ACTIVATION; SOLUBLE CD30; MARKERS; IMMUNE; CD23; CYTOKINES;
D O I：
10.1038/leu.2015.2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1429 / 1431
页数：3
相关论文
共 15 条
  • [1] [Anonymous], 1994, Ann Epidemiol, V4, P1
  • [2] Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity?
    Croft, M
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (08) : 609 - 620
  • [3] Markers of B-Cell Activation in Relation to Risk of Non-Hodgkin Lymphoma
    De Roos, Anneclaire J.
    Mirick, Dana K.
    Edlefsen, Kerstin L.
    LaCroix, Andrea Z.
    Kopecky, Kenneth J.
    Madeleine, Margaret M.
    Magpantay, Larry
    Martinez-Maza, Otoniel
    [J]. CANCER RESEARCH, 2012, 72 (18) : 4733 - 4743
  • [4] Del PG, 1995, FASEB J, V9, P81
  • [5] FOURNIER S, 1994, BLOOD, V84, P1881
  • [6] CD23 AND B-CELL ACTIVATION
    GORDON, J
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 1992, 22 (02) : 199 - 204
  • [7] Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study
    Gu, Yian
    Shore, Roy E.
    Arslan, Alan A.
    Koenig, Karen L.
    Liu, Mengling
    Ibrahim, Sherif
    Lokshin, Anna E.
    Zeleniuch-Jacquotte, Anne
    [J]. CANCER CAUSES & CONTROL, 2010, 21 (08) : 1323 - 1333
  • [8] Hartge P., 2006, CANC EPIDEMIOLOGY PR, V3, P898
  • [9] Clinical Aspects of Monoclonal B-Cell Lymphocytosis
    Mowery, Yvonne M.
    Lanasa, Mark C.
    [J]. CANCER CONTROL, 2012, 19 (01) : 8 - 17
  • [10] A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma
    Purdue, Mark P.
    Hofmann, Jonathan N.
    Kemp, Troy J.
    Chaturvedi, Anil K.
    Lan, Qing
    Park, Ju-Hyun
    Pfeiffer, Ruth M.
    Hildesheim, Allan
    Pinto, Ligia A.
    Rothman, Nathaniel
    [J]. BLOOD, 2013, 122 (06) : 951 - 957
12